Financial Consulate, Inc Biomarin Pharmaceutical Inc Transaction History
Financial Consulate, Inc
- $678 Million
- Q3 2025
A detailed history of Financial Consulate, Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Financial Consulate, Inc holds 60 shares of BMRN stock, worth $3,295. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60Holding current value
$3,295% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
694Shares Held
186MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.25 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.6MShares$1.02 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.2MShares$837 Million0.65% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$830 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$675 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...